These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28439136)

  • 1. Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?
    Kufel WD; Seabury RW; Darko W; Probst LA; Miller CD
    Hosp Pharm; 2017 Mar; 52(3):214-220. PubMed ID: 28439136
    [No Abstract]   [Full Text] [Related]  

  • 2. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.
    Schloemer NJ; Abu-Sultaneh S; Hanson SJ; Yan K; Hoffmann RG; Punzalan RC; Havens PL
    Pediatr Crit Care Med; 2014 Sep; 15(7):e294-9. PubMed ID: 24901803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of anti-factor Xa monitoring in a selection of patients receiving enoxaparin at a large academic medical center.
    Sacha GL; Greenlee KM; Ketz JM
    J Thromb Thrombolysis; 2016 Nov; 42(4):479-85. PubMed ID: 27256341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an enoxaparin dosing calculator using burn size and weight.
    Faraklas I; Ghanem M; Brown A; Cochran A
    J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin dosing and monitoring in solid organ transplant recipients.
    Moten MA; Gaber AO; Putney D; Patel SJ
    Clin Transplant; 2013; 27(6):852-7. PubMed ID: 24033530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison of two enoxaparin dosing and monitoring protocols at a pediatric hospital.
    Wolsey A; Wilcox RA; Olson JA; Boehme S; Anderson CR
    Am J Health Syst Pharm; 2019 May; 76(11):815-819. PubMed ID: 31361813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.
    Fung LS; Klockau C
    J Pediatr Pharmacol Ther; 2010 Apr; 15(2):119-25. PubMed ID: 22477802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring Enoxaparin with Antifactor Xa Levels in Obese Patients.
    Lee YR; Vega JA; Duong HN; Ballew A
    Pharmacotherapy; 2015 Nov; 35(11):1007-15. PubMed ID: 26598093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?
    Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS
    Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and Pharmacokinetics of Treatment Dose Enoxaparin in Hospitalized Patients With Morbid Obesity.
    Thompson-Moore NR; Wanat MA; Putney DR; Liebl PH; Chandler WL; Muntz JE
    Clin Appl Thromb Hemost; 2015 Sep; 21(6):513-20. PubMed ID: 25601898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-therapeutic anti-Xa levels in medical patients receiving anticoagulant therapy with enoxaparin.
    Ramos-Esquivel A; Salazar-Sánchez L
    Thromb Res; 2013 Oct; 132(4):433-6. PubMed ID: 24050826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
    Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
    Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients.
    Malinoski D; Jafari F; Ewing T; Ardary C; Conniff H; Baje M; Kong A; Lekawa ME; Dolich MO; Cinat ME; Barrios C; Hoyt DB
    J Trauma; 2010 Apr; 68(4):874-80. PubMed ID: 20386282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Critical Evaluation of Enoxaparin Dose Adjustment Guidelines in Children.
    Dinh CN; Moffett BS; Galati M; Lee-Kim Y; Yee DL; Mahoney D
    J Pediatr Pharmacol Ther; 2019; 24(2):128-133. PubMed ID: 31019405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Xa monitoring of enoxaparin for acute coronary syndromes in patients with renal disease.
    Ma JM; Jackevicius CA; Yeo E
    Ann Pharmacother; 2004 Oct; 38(10):1576-81. PubMed ID: 15328396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.
    Bauman ME; Black KL; Bauman ML; Belletrutti M; Bajzar L; Massicotte MP
    Thromb Res; 2009 Apr; 123(6):845-7. PubMed ID: 19038418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of anti-factor Xa monitoring in surgical patients receiving prophylactic doses of enoxaparin for venous thromboembolism prophylaxis.
    Pannucci CJ; Prazak AM; Scheefer M
    Am J Surg; 2017 Jun; 213(6):1143-1152. PubMed ID: 27692434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
    Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
    Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit.
    Scrimenti A; Seabury RW; Miller CD; Ruangvoravat L; Darko W; Probst LA; Cwikla GM
    Pharm Pract (Granada); 2019; 17(4):1541. PubMed ID: 31897248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.